


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.11%
-1.71%
+0.19%
+0.11%
-0.01%
RPRX
Royalty Pharma plc
$44.21
Strengths

Earnings are forecast to grow

Pays a reliable dividend

Upgraded on attractively valued
RPRX Price Performance
$40.21 (+9.95%)
$39.16 (+12.90%)
$35.73 (+23.73%)
$33.37 (+32.48%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to grow
![]()
RPRX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RPRX Street Sentiment is extremely bullish and have positive views on the near-term outlook
RPRX has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Today
Upgrade
Buy
Citi
Dec 12, 2025
Reiterate
Buy
TD Cowen
Oct 11, 2025
Reiterate
Overweight
Morgan Stanley
Sep 30, 2025
Initiate
Buy
Goldman Sachs
What is RPRX current stock price?
What are RPRX stock strengths?
What is RPRX Risk Level?
What is RPRX market cap and volume?
What is RPRX current Stock IQ?
Should I buy RPRX stock right now?
Is RPRX a Strong Buy right now?
What does a 'Strong Buy' rating mean for RPRX?
What does a 'Strong Sell' rating mean for RPRX?
What factors influence RPRX's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.11%
-1.71%
+0.19%
+0.11%
-0.01%
RPRX
Royalty Pharma plc
Current Price
$44.21

RPRX Price Performance
$40.21 (+9.95%)
$39.16 (+12.90%)
$35.73 (+23.73%)
$33.37 (+32.48%)
RPRX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to grow
![]()
RPRX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RPRX Street Sentiment is extremely bullish and have positive views on the near-term outlook
RPRX has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Today
Upgrade
Buy
Citi
Dec 12, 2025
Reiterate
Buy
TD Cowen
Oct 11, 2025
Reiterate
Overweight
Morgan Stanley
Sep 30, 2025
Initiate
Buy
Goldman Sachs
RPRX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Pays a reliable dividend

Upgraded on attractively valued
RPRX Latest Analysis
Exploring Analyst Estimates for Royalty Pharma (RPRX) Q4 Earnings Beyond Revenue and EPS. Looking beyond Wall Streets top-and-bottom-line estimate forecasts for Royalty Pharma (RPRX) delve into some of its key metrics to gain a deeper insight into the companys potential performance for the quarter ended December 2025.
Tue Feb 10, 2026
UBS and Citi Are ish on Royalty Pharma Plc (RPRX) – Heres Why. Royalty Pharma Plc (NASDAQ:RPRX) is one of the best healthcare stocks under $50 to invest in. On January 30 Royalty Pharma Plc (NASDAQ:RPRX) was upgraded to Buy from Neutral by UBS with the firm raising the price target on the stock to $49 from $38. The firm told investors that Royalty Pharma
Tue Feb 10, 2026
Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy?. Royalty Pharma (RPRX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wed Feb 4, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RPRX Stock trends
RPRX Stock performance
RPRX Stock analysis
RPRX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.